Murray S.  Kessler net worth and biography

Murray Kessler Biography and Net Worth

CEO of Perrigo
Murray S. Kessler serves as President, Chief Executive Officer, Director of the Company. Before joining Perrigo, Mr. Kessler served as the Chairman of the board of directors, President and CEO of Lorillard, Inc. (2010-2015). He served as Vice Chair of Altria, Inc. (2009) and President and CEO of UST, Inc. (2000-2009), a wholly owned subsidiary. Previous to his time at UST, Mr. Kessler had over 18 years of consumer-packaged goods experience with companies including Vlasic Foods International, Campbell Soup and The Clorox Company. In addition to his board service at Lorillard, Mr. Kessler previously served on the board of directors of Reynolds-American, Inc. from 2015 to 2017. Since 2015, Mr. Kessler has served as voluntary President of the United States Equestrian Federation.

What is Murray S. Kessler's net worth?

The estimated net worth of Murray S. Kessler is at least $74,890.76 as of May 11th, 2023. Mr. Kessler owns 2,668 shares of Perrigo stock worth more than $74,891 as of November 23rd. This net worth estimate does not reflect any other investments that Mr. Kessler may own. Learn More about Murray S. Kessler's net worth.

How do I contact Murray S. Kessler?

The corporate mailing address for Mr. Kessler and other Perrigo executives is THE SHARP BUILDING HOGAN PLACE, DUBLIN L2, 49010. Perrigo can also be reached via phone at (531) 709-4000 and via email at [email protected]. Learn More on Murray S. Kessler's contact information.

Has Murray S. Kessler been buying or selling shares of Perrigo?

Murray S. Kessler has not been actively trading shares of Perrigo within the last three months. Most recently, Murray S. Kessler sold 197,646 shares of the business's stock in a transaction on Thursday, May 11th. The shares were sold at an average price of $35.75, for a transaction totalling $7,065,844.50. Following the completion of the sale, the chief executive officer now directly owns 2,668 shares of the company's stock, valued at $95,381. Learn More on Murray S. Kessler's trading history.

Who are Perrigo's active insiders?

Perrigo's insider roster includes Bradley Alford (Director), Svend Andersen (EVP), Eduardo Bezerra (CFO), Rolf Classon (Director), James Dillard, III (EVP), Thomas Farrington (EVP), Alison Ives (EVP), Ronald Janish (EVP), Murray Kessler (CEO), Todd Kingma (VP), Patrick Lockwood-Taylor (President, CEO & Director), Geoffrey Parker (Director), Grainne Quinn (EVP), Theodore Samuels, II (Director), Raymond Silcock (CFO), Richard Sorota (EVP), and Robert Willis (EVP). Learn More on Perrigo's active insiders.

Are insiders buying or selling shares of Perrigo?

During the last twelve months, Perrigo insiders bought shares 5 times. They purchased a total of 24,540 shares worth more than $675,232.90. During the last twelve months, insiders at the sold shares 3 times. They sold a total of 50,254 shares worth more than $1,411,969.20. The most recent insider tranaction occured on September, 13th when Director Katherine C Doyle sold 8,954 shares worth more than $244,444.20. Insiders at Perrigo own 0.7% of the company. Learn More about insider trades at Perrigo.

Information on this page was last updated on 9/13/2024.

Murray S. Kessler Insider Trading History at Perrigo

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/11/2023Sell197,646$35.75$7,065,844.502,668View SEC Filing Icon  
11/9/2018Buy15,683$63.79$1,000,418.5713,416View SEC Filing Icon  
See Full Table

Murray S. Kessler Buying and Selling Activity at Perrigo

This chart shows Murray S Kessler's buying and selling at Perrigo by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Perrigo Company Overview

Perrigo logo
Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. It also offers healthy lifestyle products, such as smoking cessation, well-being, and weight management products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women's health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; rare diseases business; and other miscellaneous self-care products. The company sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, Compeed Stops, XLS, Arterin, Davitamon, Apiserum, Abtei, and Nicorette brands. It also offers contract manufacturing services. The company sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.
Read More

Today's Range

Now: $28.07
Low: $26.96
High: $28.12

50 Day Range

MA: $25.98
Low: $24.18
High: $28.21

2 Week Range

Now: $28.07
Low: $23.89
High: $34.60

Volume

1,408,270 shs

Average Volume

1,624,318 shs

Market Capitalization

$3.83 billion

P/E Ratio

N/A

Dividend Yield

4.07%

Beta

0.48